Skip to main content
Richard Williams, MD, Oncology, Concord, NC

RichardFWilliamsMDPhD

Oncology Concord, NC

Staff Hematologist Oncologist

Dr. Williams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Williams' full profile

Already have an account?

  • Office

    100 Medical Park Dr
    Ste 110
    Concord, NC 28025
    Phone+1 704-403-1370
    Fax+1 704-403-1389

Education & Training

  • Madigan Army Medical Center
    Madigan Army Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
  • William Beaumont Army Medical Center
    William Beaumont Army Medical CenterResidency, Internal Medicine, 1988 - 1991
  • University of Arkansas For Medical Sciences College of Medicine
    University of Arkansas For Medical Sciences College of MedicineClass of 1988

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1992 - 2025
  • AR State Medical License
    AR State Medical License 1989 - 2010
  • WV State Medical License
    WV State Medical License 1998 - 2001
  • WA State Medical License
    WA State Medical License 1997 - 1998
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
  • Fellow (FACP) American College of Physicians, 2002

Press Mentions

  • First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a Single Agent and in Combination with Binimetinib in BRAF-Altered Cancers and NRAS Mutant Melanoma
    First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a Single Agent and in Combination with Binimetinib in BRAF-Altered Cancers and NRAS Mutant MelanomaApril 17th, 2023
  • Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer
    Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical OfficerJuly 8th, 2020
  • Edinburgh's Sick Kids Consortium Not yet Committed to Crucial Upgrade at Hospital
    Edinburgh's Sick Kids Consortium Not yet Committed to Crucial Upgrade at HospitalOctober 2nd, 2019
  • Join now to see all

Professional Memberships